5α-Reductase inhibition by finasteride (proscar®) in epithelium and stroma of human benign prostatic hyperplasia
- 30 November 1994
- Vol. 59 (11) , 616-620
- https://doi.org/10.1016/0039-128x(94)90016-7
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Finasteride (MK‐906) in the treatment of benign prostatic hyperplasiaThe Prostate, 1993
- The Effect of Finasteride in Men with Benign Prostatic HyperplasiaNew England Journal of Medicine, 1992
- The clinical development of a 5α-reductase inhibitor, finasterideThe Journal of Steroid Biochemistry and Molecular Biology, 1990
- Effect of Aging on Kinetic Parameters of 3α(β)-Hydroxysteroid Oxidoreductases in Epithelium and Stroma of Human Normal and Hyperplastic ProstateJournal of Clinical Endocrinology & Metabolism, 1990
- Effect of Aging on Kinetic Parameters of 5α-Reductase in Epithelium and Stroma of Normal and Hyperplastic Human Prostate*Journal of Clinical Endocrinology & Metabolism, 1988
- Azasteroids: structure-activity relationships for inhibition of 5.alpha.-reductase and of androgen receptor bindingJournal of Medicinal Chemistry, 1986
- Species Differences in Prostatic Steroid 5α-Reductases of Rat, Dog, and HumanEndocrinology, 1985
- ROLE OF THE MESENCHYME IN THE INDUCTION OF THE RAT PROSTATE GLAND BY ANDROGENS IN ORGAN CULTUREJournal of Endocrinology, 1979
- QUANTIFICATION OF ANDROGEN BINDING, ANDROGEN TISSUE LEVELS, AND SEX HORMONE-BINDING GLOBULIN IN PROSTATE, MUSCLE AND PLASMA OF PATIENTS WITH BENIGN PROSTATIC HYPERTROPHYActa Endocrinologica, 1977
- Epithelial-Stromal Interactions in Development of the Urogenital TractPublished by Elsevier ,1976